Patient P-01560
Synthetic patientNBL-101 · Day 114 · 25–34 · M · baseline S19Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
28%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S19
- Day 31 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 31.
Primary contributors, last 14 days
- Toxicity+14
- Inflammatory activity+6
- Nutritional resilience-5
- Treatment adherence-4
- GI instability-3
What helped?
No interventions yet.
LIFE OS recommendation
Dietary Support Protocol NP-02
62%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 10 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion36.7/100
improving · -2.8 vs previous 14 d
Toxicity
Blood33.7/100
worsening · +6.7 vs previous 14 d
Sleep quality
Wearable61.4/100
stable · +0.3 vs previous 14 d
Energy level
Daily log5.8/10
improving · +0.3 vs previous 14 d
Stress level
Daily log6.5/10
worsening · +0.2 vs previous 14 d
Steps
Wearable7,070
stable · +239 vs previous 14 d
Adherence
Companion94.8 %
worsening · -5.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 55 from the failing basin, 32 from restoration.
Would help
- NP-02 Dietary Support Protocol74% improved among 23 similar · onset 10 d · confidence 50%
Would not help
- HY-01 Hydration Protocolonly 33% improved among 9 similar
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol-1.8no signal · 33%
- Histamine load-1.7no signal · 26%
- Dietary fat load-1no signal · 15%
- Simple carbohydrates-0.9no signal · 15%
- Spicy / capsaicin-0.5no signal · 15%
- Insoluble fibre+0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑65
- DNAIL6 -174 variant raises baseline inflammatory tone
- BloodInflammatory load index 43
- WearableHRV 25 ms, trending down
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↓25
- WearableResting HR 76 bpm
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4 · butyrate capacity 72/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 27 ms
- Sleep
- 7.6 h
- Steps
- 7,072
- Resting HR
- 72 bpm
Daily log: GI score 37, nutritional resilience 50, adherence 95.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.